• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Penumbra (PEN)

Sell: $255.55|Buy: $379.00|Change: 0.62 (-0.20%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Address

One Penumbra Place
Alameda
CA
USA
94502

Telephone

+1 510 9952461

Website

https://www.penumbrainc.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Penumbra Inc Third Quarter Earnings Conference Call for 20262026-11-05T16:30:00
Penumbra Inc Third Quarter Earnings Results for 20262026-11-05T00:00:00
Penumbra Inc Second Quarter Earnings Conference Call for 20262026-07-29T16:30:00
Penumbra Inc Second Quarter Earnings Results for 20262026-07-29T00:00:00
Penumbra Inc Annual General Meeting for 20262026-05-28T11:00:00
Penumbra Inc First Quarter Earnings Conference Call for 20262026-04-23T16:30:00
Penumbra Inc First Quarter Earnings Results for 20262026-04-23T00:00:00
Penumbra Inc Fourth Quarter Earnings Conference Call for 20252026-02-18T16:30:00
Penumbra Inc Fourth Quarter Earnings Results for 20252026-02-18T00:00:00
Penumbra Inc Annual Report for 20252026-02-18T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-12T18:45:00
Piper Sandler 37th Annual Healthcare Conference2025-12-03T08:00:00

Previous key dates

NameKey Date
Piper Sandler 37th Annual Healthcare Conference2025-12-03T08:00:00
Penumbra Inc Third Quarter Earnings Conference Call for 20252025-11-05T16:30:00
Penumbra Inc Third Quarter Earnings Result for 20252025-11-05T00:00:00
TCT Conference2025-10-26T16:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T13:50:00
2025 Wells Fargo Healthcare Conference2025-09-03T08:45:00
Penumbra Inc Second Quarter Earnings Conference Call for 20252025-07-29T16:30:00
Penumbra Inc Second Quarter Earnings Result for 20252025-07-29T00:00:00
Penumbra Inc Annual General Meeting for 20252025-05-28T11:00:00
BofA Securities 2025 Health Care Conference2025-05-13T18:00:00
Penumbra Inc First Quarter Earnings Conference Call for 20252025-04-23T16:30:00
Penumbra Inc First Quarter Earnings Results for 20252025-04-23T00:00:00
Penumbra Inc Fourth Quarter Earnings Conference Call for 20242025-02-18T16:30:00
Penumbra Inc Fourth Quarter Earnings Results for 20242025-02-18T00:00:00
Penumbra Inc Annual Report for 20242025-02-18T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T18:00:00
Penumbra Inc Piper Sandler 36th Annual Healthcare Conference 20242024-12-04T08:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.